AU2196500A - Methods and compositions for decreasing allergic reactions to surface allergens - Google Patents

Methods and compositions for decreasing allergic reactions to surface allergens Download PDF

Info

Publication number
AU2196500A
AU2196500A AU21965/00A AU2196500A AU2196500A AU 2196500 A AU2196500 A AU 2196500A AU 21965/00 A AU21965/00 A AU 21965/00A AU 2196500 A AU2196500 A AU 2196500A AU 2196500 A AU2196500 A AU 2196500A
Authority
AU
Australia
Prior art keywords
allergen
ige
masking
composition
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21965/00A
Other languages
English (en)
Inventor
Michael Caplan
Howard Sosin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2196500A publication Critical patent/AU2196500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU21965/00A 1998-12-18 1999-12-17 Methods and compositions for decreasing allergic reactions to surface allergens Abandoned AU2196500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21611798A 1998-12-18 1998-12-18
US09216117 1998-12-18
PCT/US1999/030238 WO2000035484A2 (en) 1998-12-18 1999-12-17 Methods and compositions for decreasing allergic reactions to surface allergens

Publications (1)

Publication Number Publication Date
AU2196500A true AU2196500A (en) 2000-07-03

Family

ID=22805772

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21965/00A Abandoned AU2196500A (en) 1998-12-18 1999-12-17 Methods and compositions for decreasing allergic reactions to surface allergens

Country Status (6)

Country Link
US (1) US20010051155A1 (enExample)
EP (1) EP1140169A2 (enExample)
JP (1) JP2004538237A (enExample)
AU (1) AU2196500A (enExample)
CA (1) CA2355650A1 (enExample)
WO (1) WO2000035484A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020019009A1 (en) * 1999-12-09 2002-02-14 Roggen Erwin Ludo High throughput screening (HTS) assays
US7060687B2 (en) 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
US20020197268A1 (en) * 2001-06-08 2002-12-26 Hsu Ching-Hsaing Allergen-containing milk for allergy treatment
JP3642340B2 (ja) * 2003-03-28 2005-04-27 ダイキン工業株式会社 有害物質除去方法、並びに、それに用いる空気浄化用フィルタ、拭き取りシートなどの有害物質除去材、及び、その保管方法
CA2693416C (en) * 2007-07-09 2018-01-09 Nestec S.A. Methods for reducing allergies caused by environmental allergens
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
EP2022507A1 (en) * 2007-08-07 2009-02-11 Universität Hamburg Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
US8962241B2 (en) * 2010-07-20 2015-02-24 California Institute Of Technology Triggered molecular geometry based bioimaging probes
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
EP3760223A1 (en) 2013-04-03 2021-01-06 N-Fold Llc Nanoparticle composition for desensitizing a subject to peanut allergens
EP3631464A1 (en) * 2017-05-25 2020-04-08 Société des Produits Nestlé S.A. Methods for enabling pet ownership

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512283A (en) * 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
JPH08501799A (ja) * 1992-12-21 1996-02-27 タノックス バイオシステムズ インコーポレイテッド アレルゲン特異的ＩｇＡモノクローナル抗体及びアレルギー治療のための関連物質
WO1995012420A1 (en) * 1993-11-04 1995-05-11 Bsi Corporation Barrier coatings for surfaces

Also Published As

Publication number Publication date
CA2355650A1 (en) 2000-06-22
WO2000035484A3 (en) 2000-10-19
EP1140169A2 (en) 2001-10-10
US20010051155A1 (en) 2001-12-13
WO2000035484A2 (en) 2000-06-22
JP2004538237A (ja) 2004-12-24

Similar Documents

Publication Publication Date Title
DE69931377T2 (de) Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
CA2319437C (en) Methods and reagents for decreasing allergic reactions
Chan-Yeung et al. Aetiological agents in occupational asthma
US5670626A (en) Allergen-specific human IgA monoclonal antibodies for mucosal administration
US20010051155A1 (en) Methods and compositions for decreasing allergic reactions to surface allergens
EP1322330B1 (en) Modulation of allergic response
TW201030341A (en) Method for identifying allergenic proteins and peptides
Chippaux et al. Production and use of snake antivenin
JP2004538237A5 (enExample)
Khurana et al. Allergenic extracts to diagnose and treat sensitivity to insect venoms and inhaled allergens
JP4554728B2 (ja) 移植片拒絶反応またはアレルギーまたは自己免疫反応と関連した病状を治療するための医薬または食品組成物
JP6073239B2 (ja) 抗原隠蔽剤としての使用のための、ヒトラクトフェリン誘導ペプチド
JP2003527438A (ja) アレルギーの予防及び／又は治療用組成物及びアレルギーの予防及び／又は治療方法
WO2005028622A2 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
WO2000052154A2 (en) Methods and reagents for decreasing clinical reaction to allergy
Arbesman et al. Allergenic potency of bee antigens measured by RAST inhibition
Özdemir Cockroach allergy, respiratory allergic diseases and its immunotherapy
EP0888541B1 (en) Cryptic peptides and method for their identification
JPH06510752A (ja) アレルギー治療のためのｐ物質の使用方法
NZ505179A (en) Immune suppressive food product comprising polypeptide fragments of allergens
Offerle et al. The history of allergic disease between 1971 and 2017: How much do changes in human activity explain the rise in three separate forms of food allergy
SHARMA et al. PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST INDIAN PAPER WASP ROPALIDIA MARGINATA VENOM TOXINS AND THEIR EFFICACY IN THE REVERSAL OF TOXIC EFFECTS
JP2918795B2 (ja) アレルギー疾患治療のための植物自己不和合性受容体蛋白（ｓｌｇおよびｓｒｋ）組成物
Gepp Investigation of antibody responses of birch pollen allergic individuals by using chimeric allergens
Chapman et al. Cockroach allergens, environmental exposure, and asthma